Stocks and Investing
Stocks and Investing
Thu, April 27, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Sean Dodge Reiterated (TDOC) at Buy and Held Target at $35 on, Apr 27th, 2023
Sean Dodge of RBC Capital, Reiterated "Teladoc Health, Inc." (TDOC) at Buy and Held Target at $35 on, Apr 27th, 2023.
Sean has made no other calls on TDOC in the last 4 months.
There are 9 other peers that have a rating on TDOC. Out of the 9 peers that are also analyzing TDOC, 5 agree with Sean's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Jeff Garro of "Stephens & Co." Initiated at Hold and Held Target at $25 on, Wednesday, April 12th, 2023
- Stan Berenshteyn of "Wells Fargo" Maintained at Hold with Decreased Target to $23 on, Monday, March 6th, 2023
- Lisa Gill of "JP Morgan" Maintained at Hold with Decreased Target to $33 on, Monday, February 27th, 2023
- George Hill of "Deutsche Bank" Maintained at Hold with Decreased Target to $27 on, Monday, February 27th, 2023
- Marc Solecitto of "Barclays" Maintained at Hold with Decreased Target to $28 on, Wednesday, January 18th, 2023
These are the ratings of the 4 analyists that currently disagree with Sean
- Richard Close of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $36 on, Monday, March 6th, 2023
- Stephanie Davis of "SVB Leerink" Upgraded from Hold to Buy and Held Target at $34 on, Thursday, February 23rd, 2023
- Michael Wiederhorn of "Oppenheimer" Maintained at Buy with Decreased Target to $35 on, Thursday, February 23rd, 2023
- Colin Rusch of "Oppenheimer" Maintained at Buy with Decreased Target to $37 on, Thursday, January 19th, 2023
Contributing Sources